Rise and shine. Another busy day is on the way. And there have been a lot of busy days recently, yes? Meetings and deadlines, deadlines and meetings. It never stops. To cope, we are brewing that mandatory cup of stimulation as we tackle our own version of R&D. Meanwhile, here are a few items of interest to help you along. We hope your day goes well and that you conquer the world.
Merck CEO Defends R&D Spending (Reuters)
Thomas H Lee In Lead To Buy Glaxo Consumer Products (Bloomberg News)
Express Scripts And Wellpoint Fight Over NextRx Deal (Bloomberg News)
Bristol-Myers Expand Research Deal With China's Simcere (Pharma Times)
Specialist ECG Firms Preferred Over Big CROs: Survey (Outsourcing Pharma)
EDITOR'S NOTE: Please check this post for updates throughout the morning